Cellectis CLLS
NASDAQ CLLS
$1.43 +0.03 (+2.14%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cellectis (CLLS) Return on Capital Employed [ROCE] (2015 - 2026)

Updated

Cellectis' Return on Capital Employed [ROCE] came in at -21.42% for Q2 2026, up 2.18 percentage points from -23.60% a year earlier but down 6.64 percentage points from the prior quarter.

Analysis

Cellectis (CLLS) Return on Capital Employed [ROCE] (2015 - 2026) Analysis & Trends

For FY2025, Cellectis' Return on Capital Employed [ROCE] was -9.62%, up 7.75 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a five-year change of +0.73 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -17.37% in FY2024 (+15.90 pp), -33.27% in FY2023 (-4.95 pp), -28.33% in FY2022 (-3.89 pp) and -24.44% in FY2021 (-14.08 pp).
  • The five-year range for quarterly Return on Capital Employed [ROCE] is -44.29% (Q2 2022) to -7.99% (Q3 2025).
  • Year-over-year, Return on Capital Employed [ROCE] has increased for ten consecutive quarters, with an average year-over-year change of +11.49 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q3 2024 (a gain of 22.19 percentage points), and the weakest in Q2 2022 (a drop of 32.36 percentage points).
  • Business Quant data shows CLLS's Return on Capital Employed [ROCE] at -14.78% (Q1 2026), -10.23% (Q4 2025) and -7.99% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Cellectis 143.49 Mn -609.91 Mn - -21.42%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -21.42%
Mar 31, 2026 -14.78%
Dec 31, 2025 -10.23%
Sep 30, 2025 -7.99%
Jun 30, 2025 -23.60%
Mar 31, 2025 -14.80%
Dec 31, 2024 -15.94%
Sep 30, 2024 -19.80%
Jun 30, 2024 -39.95%
Mar 31, 2024 -27.94%
Dec 31, 2023 -36.48%
Sep 30, 2023 -42.00%
Jun 30, 2023 -40.54%
Mar 31, 2023 -33.35%
Dec 31, 2022 -33.75%
Sep 30, 2022 -37.42%
Jun 30, 2022 -44.29%
Mar 31, 2022 -37.96%
Dec 31, 2021 -31.46%
Sep 30, 2021 -15.71%
API Access

Cellectis Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CLLS&period=max&api_key=YOUR_API_KEY